First treatment with Q-PRO[®] and integrated image management technology
The first treatment with the new generation of SpectraCure's Q-PRO[®] treatment system and the integrated image management technology has been performed at Memorial Sloan Kettering Cancer Center in New York.SpectraCure's new generation of the treatment system Q-PRO[®] and the integrated ultrasound image management technology from MedCom in Germany, has previously been approved by the FDA for use in the clinical study for the treatment of recurrent prostate cancer. The first treatment has now been performed with Q-PRO[®] and the new integrated image management technology. The treatment was